1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Cimzia 1.2.3 Enbrel 1.2.4 Humira 1.2.5 Remicade 1.2.6 Simponi 1.2.7 Others 1.3 Market by Application 1.3.1 Global Ankylosing Spondylitis Drug Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ankylosing Spondylitis Drug Market Perspective (2017-2028) 2.2 Ankylosing Spondylitis Drug Growth Trends by Region 2.2.1 Ankylosing Spondylitis Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Ankylosing Spondylitis Drug Historic Market Size by Region (2017-2022) 2.2.3 Ankylosing Spondylitis Drug Forecasted Market Size by Region (2023-2028) 2.3 Ankylosing Spondylitis Drug Market Dynamics 2.3.1 Ankylosing Spondylitis Drug Industry Trends 2.3.2 Ankylosing Spondylitis Drug Market Drivers 2.3.3 Ankylosing Spondylitis Drug Market Challenges 2.3.4 Ankylosing Spondylitis Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ankylosing Spondylitis Drug Players by Revenue 3.1.1 Global Top Ankylosing Spondylitis Drug Players by Revenue (2017-2022) 3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2017-2022) 3.2 Global Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue 3.4 Global Ankylosing Spondylitis Drug Market Concentration Ratio 3.4.1 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Drug Revenue in 2021 3.5 Ankylosing Spondylitis Drug Key Players Head office and Area Served 3.6 Key Players Ankylosing Spondylitis Drug Product Solution and Service 3.7 Date of Enter into Ankylosing Spondylitis Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ankylosing Spondylitis Drug Breakdown Data by Type 4.1 Global Ankylosing Spondylitis Drug Historic Market Size by Type (2017-2022) 4.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2023-2028) 5 Ankylosing Spondylitis Drug Breakdown Data by Application 5.1 Global Ankylosing Spondylitis Drug Historic Market Size by Application (2017-2022) 5.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Ankylosing Spondylitis Drug Market Size (2017-2028) 6.2 North America Ankylosing Spondylitis Drug Market Size by Country (2017-2022) 6.3 North America Ankylosing Spondylitis Drug Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Ankylosing Spondylitis Drug Market Size (2017-2028) 7.2 Europe Ankylosing Spondylitis Drug Market Size by Country (2017-2022) 7.3 Europe Ankylosing Spondylitis Drug Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size (2017-2028) 8.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Country (2017-2022) 8.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Ankylosing Spondylitis Drug Market Size (2017-2028) 9.2 Latin America Ankylosing Spondylitis Drug Market Size by Country (2017-2022) 9.3 Latin America Ankylosing Spondylitis Drug Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size (2017-2028) 10.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2017-2022) 10.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Detail 11.1.2 Amgen Business Overview 11.1.3 Amgen Ankylosing Spondylitis Drug Introduction 11.1.4 Amgen Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.1.5 Amgen Recent Development 11.2 Wyeth 11.2.1 Wyeth Company Detail 11.2.2 Wyeth Business Overview 11.2.3 Wyeth Ankylosing Spondylitis Drug Introduction 11.2.4 Wyeth Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.2.5 Wyeth Recent Development 11.3 Takeda 11.3.1 Takeda Company Detail 11.3.2 Takeda Business Overview 11.3.3 Takeda Ankylosing Spondylitis Drug Introduction 11.3.4 Takeda Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.3.5 Takeda Recent Development 11.4 Centocor 11.4.1 Centocor Company Detail 11.4.2 Centocor Business Overview 11.4.3 Centocor Ankylosing Spondylitis Drug Introduction 11.4.4 Centocor Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.4.5 Centocor Recent Development 11.5 Schering-Plough 11.5.1 Schering-Plough Company Detail 11.5.2 Schering-Plough Business Overview 11.5.3 Schering-Plough Ankylosing Spondylitis Drug Introduction 11.5.4 Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.5.5 Schering-Plough Recent Development 11.6 Mitsubishi Tanabe 11.6.1 Mitsubishi Tanabe Company Detail 11.6.2 Mitsubishi Tanabe Business Overview 11.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Introduction 11.6.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.6.5 Mitsubishi Tanabe Recent Development 11.7 Abbott 11.7.1 Abbott Company Detail 11.7.2 Abbott Business Overview 11.7.3 Abbott Ankylosing Spondylitis Drug Introduction 11.7.4 Abbott Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.7.5 Abbott Recent Development 11.8 Eisai 11.8.1 Eisai Company Detail 11.8.2 Eisai Business Overview 11.8.3 Eisai Ankylosing Spondylitis Drug Introduction 11.8.4 Eisai Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.8.5 Eisai Recent Development 11.9 Pfizer 11.9.1 Pfizer Company Detail 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Ankylosing Spondylitis Drug Introduction 11.9.4 Pfizer Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.9.5 Pfizer Recent Development 11.10 Johnson & Johnson 11.10.1 Johnson & Johnson Company Detail 11.10.2 Johnson & Johnson Business Overview 11.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Introduction 11.10.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2017-2022) 11.10.5 Johnson & Johnson Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Cimzia Table 3. Key Players of Enbrel Table 4. Key Players of Humira Table 5. Key Players of Remicade Table 6. Key Players of Simponi Table 7. Key Players of Others Table 8. Global Ankylosing Spondylitis Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Ankylosing Spondylitis Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Ankylosing Spondylitis Drug Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Ankylosing Spondylitis Drug Market Share by Region (2017-2022) Table 12. Global Ankylosing Spondylitis Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Ankylosing Spondylitis Drug Market Share by Region (2023-2028) Table 14. Ankylosing Spondylitis Drug Market Trends Table 15. Ankylosing Spondylitis Drug Market Drivers Table 16. Ankylosing Spondylitis Drug Market Challenges Table 17. Ankylosing Spondylitis Drug Market Restraints Table 18. Global Ankylosing Spondylitis Drug Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Ankylosing Spondylitis Drug Market Share by Players (2017-2022) Table 20. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ankylosing Spondylitis Drug as of 2021) Table 21. Ranking of Global Top Ankylosing Spondylitis Drug Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Ankylosing Spondylitis Drug Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Ankylosing Spondylitis Drug Product Solution and Service Table 25. Date of Enter into Ankylosing Spondylitis Drug Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Ankylosing Spondylitis Drug Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2017-2022) Table 29. Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2023-2028) Table 31. Global Ankylosing Spondylitis Drug Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2017-2022) Table 33. Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2023-2028) Table 35. North America Ankylosing Spondylitis Drug Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Ankylosing Spondylitis Drug Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Ankylosing Spondylitis Drug Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe Ankylosing Spondylitis Drug Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America Ankylosing Spondylitis Drug Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America Ankylosing Spondylitis Drug Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2023-2028) & (US$ Million) Table 45. Amgen Company Detail Table 46. Amgen Business Overview Table 47. Amgen Ankylosing Spondylitis Drug Product Table 48. Amgen Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 49. Amgen Recent Development Table 50. Wyeth Company Detail Table 51. Wyeth Business Overview Table 52. Wyeth Ankylosing Spondylitis Drug Product Table 53. Wyeth Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 54. Wyeth Recent Development Table 55. Takeda Company Detail Table 56. Takeda Business Overview Table 57. Takeda Ankylosing Spondylitis Drug Product Table 58. Takeda Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 59. Takeda Recent Development Table 60. Centocor Company Detail Table 61. Centocor Business Overview Table 62. Centocor Ankylosing Spondylitis Drug Product Table 63. Centocor Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 64. Centocor Recent Development Table 65. Schering-Plough Company Detail Table 66. Schering-Plough Business Overview Table 67. Schering-Plough Ankylosing Spondylitis Drug Product Table 68. Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 69. Schering-Plough Recent Development Table 70. Mitsubishi Tanabe Company Detail Table 71. Mitsubishi Tanabe Business Overview Table 72. Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Table 73. Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 74. Mitsubishi Tanabe Recent Development Table 75. Abbott Company Detail Table 76. Abbott Business Overview Table 77. Abbott Ankylosing Spondylitis Drug Product Table 78. Abbott Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 79. Abbott Recent Development Table 80. Eisai Company Detail Table 81. Eisai Business Overview Table 82. Eisai Ankylosing Spondylitis Drug Product Table 83. Eisai Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 84. Eisai Recent Development Table 85. Pfizer Company Detail Table 86. Pfizer Business Overview Table 87. Pfizer Ankylosing Spondylitis Drug Product Table 88. Pfizer Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 89. Pfizer Recent Development Table 90. Johnson & Johnson Company Detail Table 91. Johnson & Johnson Business Overview Table 92. Johnson & Johnson Ankylosing Spondylitis Drug Product Table 93. Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2017-2022) & (US$ Million) Table 94. Johnson & Johnson Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global Ankylosing Spondylitis Drug Market Share by Type: 2021 VS 2028 Figure 2. Cimzia Features Figure 3. Enbrel Features Figure 4. Humira Features Figure 5. Remicade Features Figure 6. Simponi Features Figure 7. Others Features Figure 8. Global Ankylosing Spondylitis Drug Market Share by Application in 2021 & 2028 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Ankylosing Spondylitis Drug Report Years Considered Figure 12. Global Ankylosing Spondylitis Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Ankylosing Spondylitis Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Ankylosing Spondylitis Drug Market Share by Region: 2021 VS 2028 Figure 15. Global Ankylosing Spondylitis Drug Market Share by Players in 2021 Figure 16. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ankylosing Spondylitis Drug as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Drug Revenue in 2021 Figure 18. North America Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Ankylosing Spondylitis Drug Market Share by Country (2017-2028) Figure 20. United States Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Ankylosing Spondylitis Drug Market Share by Country (2017-2028) Figure 24. Germany Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Region (2017-2028) Figure 32. China Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Ankylosing Spondylitis Drug Market Share by Country (2017-2028) Figure 40. Mexico Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Country (2017-2028) Figure 44. Turkey Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Ankylosing Spondylitis Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Amgen Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 47. Wyeth Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 48. Takeda Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 49. Centocor Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 50. Schering-Plough Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 51. Mitsubishi Tanabe Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 52. Abbott Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 53. Eisai Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 54. Pfizer Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 55. Johnson & Johnson Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Amgen Wyeth Takeda Centocor Schering-Plough Mitsubishi Tanabe Abbott Eisai Pfizer Johnson & Johnson